# Allogene Therapeutics, Inc.: Form 8-K/A, filed Oct 17, 2023

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K/A
- Filed: 2023-10-17
- Accepted by EDGAR: Oct 17, 2023, 16:34 ET
- Period: 2023-10-16
- Accession: 0001737287-23-000083
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000083/allo-20231016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000083/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000173728723000083/allo-20231016.htm

Filed Oct 17, 2023.
Source: SEC EDGAR, the filing index for accession 0001737287-23-000083. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.